The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2007, 179, 8509 -8518
Copyright © 2007 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gainers, M. E.
Right arrow Articles by Dimitroff, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gainers, M. E.
Right arrow Articles by Dimitroff, C. J.

Skin-Homing Receptors on Effector Leukocytes Are Differentially Sensitive to Glyco-Metabolic Antagonism in Allergic Contact Dermatitis1

Madeliene E. Gainers, Leyla Descheny, Steven R. Barthel, Luzheng Liu, Marc-André Wurbel and Charles J. Dimitroff2

Harvard Skin Disease Research Center, Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115

T cell recruitment into inflamed skin is dependent on skin-homing receptor binding to endothelial (E)- and platelet (P)-selectin. These T cell receptors, or E- and P-selectin ligands, can be targeted by the metabolic fluorosugar inhibitor, 4-F-GlcNAc, to blunt cutaneous inflammation. Compelling new data indicate that, in addition to T cells, NK cells are also recruited to inflamed skin in allergic contact hypersensitivity (CHS) contingent on E- and P-selectin-binding. Using a model of allergic CHS, we evaluated the identity and impact of NK cell E-selectin ligand(s) on inflammatory responses and examined the oral efficacy of 4-F-GlcNAc. We demonstrated that the predominant E-selectin ligands on NK cells are P-selectin glycoprotein ligand-1 and protease-resistant glycolipids. We showed that, unlike the induced E-selectin ligand expression on activated T cells upon exposure to Ag, ligand expression on NK cells was constitutive. CHS responses were significantly lowered by orally administered 4-F-GlcNAc treatment. Although E-selectin ligand on activated T cells was suppressed, ligand expression on NK cells was insensitive to 4-F-GlcNAc treatment. These findings indicate that downregulating effector T cell E- and P-selectin ligand expression directly correlates with anti-inflammatory efficacy and provides new insight on metabolic discrepancies of E-selectin ligand biosynthesis in effector leukocytes in vivo.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by an American Cancer Society Grant RSG-06–024-01-CSM (to C.J.D.), National Institutes of Health/National Cancer Institute Grants CA102913 (to C.J.D.) and CA118124 (to C.J.D.), and National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant 5P30 AR042689–14 (to T.S.K.).

2 Address correspondence and reprint requests to Dr. Charles J. Dimitroff, Harvard Institutes of Medicine, Room 650, 77 Avenue Louis Pasteur, Boston, MA 02115. E-mail address: cdimitroff{at}rics.bwh.harvard.edu

3 Abbreviations used in this paper: CHS, contact hypersensitivity; P, platelet; E, endothelial; L, leukocyte; PSGL-1, P-selectin glycoprotein ligand-1; wt, wild type; p.o., orally; LN, lymph nodes; DNFB, 2,4-dinitrofluorobenzene; ILN, inguinal LN; ESL-1, E-selectin ligand-1.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
S. R. Barthel, G. K. Wiese, J. Cho, M. J. Opperman, D. L. Hays, J. Siddiqui, K. J. Pienta, B. Furie, and C. J. Dimitroff
Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking
PNAS, November 17, 2009; 106(46): 19491 - 19496.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Bianchi, L. B. Pincus, M.-A. Wurbel, B. E. Rich, T. S. Kupper, R. C. Fuhlbrigge, and M. Boes
Maintenance of Peripheral Tolerance through Controlled Tissue Homing of Antigen-Specific T Cells in K14-mOVA Mice
J. Immunol., April 15, 2009; 182(8): 4665 - 4674.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.